Search Results 741-750 of 38974 for Two-phase

  1. ABT-888 With Cyclophosphamide in Refractory BRCA-Positive Ovarian, Primary Peritoneal or Ovarian High-Grade Serous Carcinoma, Fallopian Tube Cancer, Triple-Negative Breast Cancer, and Low-Grade Non-Hodgkin's Lymphoma - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations - Mayo Clinic

    Patients will be enrolled in two stages: dose escalation stage (Stage I) and expansion stage (Stage II). Participation eligibility. Participant eligibility ...

  3. Phase 2/3 Open-Label Trial Of Sibeprenlimab In The Treatment Of Immunoglobulin A Nephropathy - Mayo Clinic

    This is a phase 2/3 open-label trial to evaluate the long-term safety, tolerability, and efficacy of sibeprenlimab administered subcutaneously (SC) in subjects ...

  4. Study To Assess The Efficacy, Safety, And Tolerability Of NOC-110 In Adults With Refractory Or Unexplained Chronic Cough - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Cervical length: Why does it matter during pregnancy? - Mayo Clinic

    Just before labor, the cervix gets shorter. In the final stage of pregnancy, the cervix opens as the body gets ready to give birth. If the cervix begins to open ...

  6. Neurology - Clinical trials - Mayo Clinic

    To accomplish this aim CREST-H will add on to the NINDS-sponsored CREST-2 trial (parallel, outcome-blinded Phase ... stage (PAF), and even at a prodromal stage ( ...

  7. Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA - Mayo Clinic

    Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA · Overview · Participation eligibility · Participating Mayo Clinic ...

  8. LEAP 2 Chronic EFS - Mayo Clinic

    In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new ...

  9. Clinical trials - Oncology (Medical)

    The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

  10. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...